05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceutical preparations, in the form of a capsule, liquid or tablet, for the treatment of cough-cold, gallbladder, gallstone, liver, muscluoskeletal, or neurological conditions, or pharmaceutical preparations for the treatment of pain
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceutical preparations for the treatment of neurological diseases or psychiatric conditions; pharmaceutical preparations for the treatment of pain
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceutical preparations for the relief of discomfort associated with acute musculoskeletal conditions; pharmaceutical preparations for the treatment of pain
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceutical preparations, in the form of a tablet and capsule, for the treatment of liver, gallbladder and gallstone conditions; pharmaceutical preparations for the treatment of pain
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceutical preparations for the treatment of inflammation and pain, particularly with respect to the treatment of rheumatoid arthritis and osteoarthritis
The present invention relates to nutritional supplements to be administered to, or to be taken by, women desiring to become pregnant, and pregnant and nursing women. The nutritional supplements of this invention have a unique blend of one or more folic acid materials, vitamins and minerals and a nutritionally acceptable carrier therefor. The invention describes specific nutritional supplements for the uses set forth above.
A61K 31/202 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having three or more double bonds, e.g. linolenic acid
A61K 31/675 - Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
A61K 31/7076 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
A61K 31/661 - Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion
A61K 31/714 - Cobalamins, e.g. cyanocobalamin, vitamin B12
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceutical preparations for the treatment of inflammation and pain, particularly with respect to the treatment of rheumatoid arthritis and osteoarthritis
16.
Nutritional supplements for treatment of iron deficiency anemia
The present invention relates to nutritional supplements to be administered to, or to be taken by, people who are subject, or thought to be subject to, iron deficiency anemia. The nutritional supplements of this invention have a unique formulation of iron and folic acid-related materials in addition to certain other vitamins and minerals and a nutritionally acceptable carrier therefor. The invention describes specific nutritional supplements for the use set forth above.
The disclosure relates to nutritional supplements to be administered to, or to be taken by, women desiring to become pregnant, and pregnant and nursing women, so that a woman (and any fetus) will be nutritionally supplemented before, during and after the gestation period. The nutritional supplements have a blend of folic acid, lycopene and co-enzyme QIO, optionally docosahexaenoic acid, and other vitamins and minerals, and a nutritionally acceptable carrier therefor, but are free or substantially free of other materials in nutritionally effective amounts. Specific nutritional supplements are described.
The present invention relates to different nutritional supplements to be administered to, or taken by, pregnant women during the first, second and third trimesters of pregnancy.
A61K 9/68 - Medicinal preparations characterised by special physical form chewing gum type
A61K 47/00 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient
A01N 45/00 - Biocides, pest repellants or attractants, or plant growth regulators containing compounds having three or more carbocyclic rings condensed among themselves, at least one ring not being a six-membered ring
The present invention relates to different nutritional supplements to be administered to, or taken by, pregnant women during the first, second and third trimesters of pregnancy.
A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
A61K 9/68 - Medicinal preparations characterised by special physical form chewing gum type
A61K 47/00 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient
A01N 45/00 - Biocides, pest repellants or attractants, or plant growth regulators containing compounds having three or more carbocyclic rings condensed among themselves, at least one ring not being a six-membered ring
The present invention relates to nutritional supplements to be administered to, or to be taken by, women desiring to become pregnant, and pregnant and nursing women. The nutritional supplements of this invention have a unique blend of vitamins, minerals, lycopene, co-enzyme Q10, DHA, docusate (such as docusate sodium), folic acid, and a nutritionally acceptable carrier therefor. The invention includes specific nutritional supplements for the uses set forth above.
A61K 47/00 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient
The present invention relates to nutritional supplements to be administered to, or to be taken by, women desiring to become pregnant, and pregnant and nursing women. The nutritional supplements of this invention have a unique blend of vitamins, minerals, lycopene, co-enzyme Q10, DHA, docusate (such as docusate sodium), folic acid, and a nutritionally acceptable carrier therefor. The invention includes specific nutritional supplements for the uses set forth above.